CMML-话题@MedSci

#CMML#

4篇内容 | 1150人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2231018, encodeId=4aa2223101832, content=<a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=7c5c490342' target=_blank style='color:#2F92EE;'>#CMML#</a>, objectTitle=CMML如果有AML典型突变(CEBPA、FLT3和NPM1)则预后不佳, objectType=article, longId=846958, objectId=0272846958f6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220801/1659342224826_8252897.webp, objectUrl=/article/show_article.do?id=0272846958f6, replyNumber=0, likeNumber=49, createdTime=2024-10-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0272846958f6, moduleTitle=CMML如果有AML典型突变(CEBPA、FLT3和NPM1)则预后不佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0272846958f6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2198266, encodeId=483e219826699, content=<a href='/topic/show?id=7c5c490342' target=_blank style='color:#2F92EE;'>#CMML#</a> <a href='/topic/show?id=29cf10212805' target=_blank style='color:#2F92EE;'>#髓系肿瘤#</a>, objectTitle=【Blood Adv】治疗相关CMML的遗传学特征：不存在治疗相关髓系肿瘤的高危特征, objectType=article, longId=821290, objectId=4fdc821290c0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-doctor-review-PTX6YZP.jpg, objectUrl=/article/show_article.do?id=4fdc821290c0, replyNumber=0, likeNumber=144, createdTime=2024-04-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4fdc821290c0, moduleTitle=【Blood Adv】治疗相关CMML的遗传学特征：不存在治疗相关髓系肿瘤的高危特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fdc821290c0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2193612, encodeId=129f2193612da, content=<a href='/topic/show?id=ed77536114a' target=_blank style='color:#2F92EE;'>#慢性粒单核细胞白血病#</a> <a href='/topic/show?id=44e9112366dd' target=_blank style='color:#2F92EE;'>#造血干细胞疾病#</a> <a href='/topic/show?id=7c5c490342' target=_blank style='color:#2F92EE;'>#CMML#</a>, objectTitle=【AJH】慢性粒单核细胞白血病的诊断、风险分层和治疗（2024更新）, objectType=article, longId=817281, objectId=0af181e281bb, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-leading-a-medical-team-at-hospital-DQZSHGT.jpg, objectUrl=/article/show_article.do?id=0af181e281bb, replyNumber=0, likeNumber=68, createdTime=2024-03-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0af181e281bb, moduleTitle=【AJH】慢性粒单核细胞白血病的诊断、风险分层和治疗（2024更新）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0af181e281bb)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1685409, encodeId=593116854095f, content=<a href='/topic/show?id=7c5c490342' target=_blank style='color:#2F92EE;'>#CMML#</a>, objectTitle=Blood：口服cedazuridine/地西他滨治疗MDS和CMML的药代动力学、疗效和安全性, objectType=article, longId=192727, objectId=297f192e2779, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=297f192e2779, replyNumber=0, likeNumber=95, createdTime=2020-11-27, rootId=0, userName=kkunny, userId=5c7c28182882, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=297f192e2779, moduleTitle=Blood：口服cedazuridine/地西他滨治疗MDS和CMML的药代动力学、疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=297f192e2779)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685408, encodeId=c29816854082d, content=<a href='/topic/show?id=7c5c490342' target=_blank style='color:#2F92EE;'>#CMML#</a>, objectTitle=Leukemia：地西他滨：高风险CMML患者的福音, objectType=article, longId=137655, objectId=927d13e655e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=927d13e655e5, replyNumber=0, likeNumber=73, createdTime=2019-01-01, rootId=0, userName=kkunny, userId=5c7c28182882, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=927d13e655e5, moduleTitle=Leukemia：地西他滨：高风险CMML患者的福音, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=927d13e655e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685407, encodeId=193e168540ed2, content=<a href='/topic/show?id=7c5c490342' target=_blank style='color:#2F92EE;'>#CMML#</a>, objectTitle=Am J Hematol：去甲基化药物治疗CMML有效吗？, objectType=article, longId=105906, objectId=6dd61059060a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dd61059060a, replyNumber=0, likeNumber=94, createdTime=2018-04-26, rootId=0, userName=kkunny, userId=5c7c28182882, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dd61059060a, moduleTitle=Am J Hematol：去甲基化药物治疗CMML有效吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6dd61059060a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685406, encodeId=cf3e16854066d, content=<a href='/topic/show?id=7c5c490342' target=_blank style='color:#2F92EE;'>#CMML#</a>, objectTitle=ASH 2014：中高危MDS和CMML的临床难题仍待探索, objectType=article, longId=44413, objectId=7a2c44413b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a2c44413b4, replyNumber=0, likeNumber=66, createdTime=2015-07-28, rootId=0, userName=kkunny, userId=5c7c28182882, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a2c44413b4, moduleTitle=ASH 2014：中高危MDS和CMML的临床难题仍待探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a2c44413b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CMML

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#AML# #CMML#

CMML如果有AML典型突变(CEBPA、FLT3和NPM1)则预后不佳

2024-10-15发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#CMML# #髓系肿瘤#

【Blood Adv】治疗相关CMML的遗传学特征：不存在治疗相关髓系肿瘤的高危特征

2024-04-13发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#慢性粒单核细胞白血病# #造血干细胞疾病# #CMML#

【AJH】慢性粒单核细胞白血病的诊断、风险分层和治疗（2024更新）

2024-03-16发表于上海

kkunny (审核中...)

前往app查看评论内容

#CMML#

Blood：口服cedazuridine/地西他滨治疗MDS和CMML的药代动力学、疗效和安全性

2020-11-27

kkunny (审核中...)

前往app查看评论内容

#CMML#

Leukemia：地西他滨：高风险CMML患者的福音

2019-01-01

kkunny (审核中...)

前往app查看评论内容

#CMML#

Am J Hematol：去甲基化药物治疗CMML有效吗？

2018-04-26

kkunny (审核中...)

前往app查看评论内容

#CMML#

ASH 2014：中高危MDS和CMML的临床难题仍待探索

2015-07-28

科室
- - 订阅+
  - 更多科室
工具
服务